1 active not recruiting, 1 completed, 1 terminated, 1 unknown. 3 Phase 2, 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Unknown 1 |
Follow Acute Megakaryoblastic Leukemia: new trials by email Literature Review of Acute Megakaryoblastic Leukemia trials Research Report on Acute Megakaryoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers Fludarabine, Cyclophosphamide, Thiotepa - Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 1 | 2022-10-06 | 2025-01-01 |
| Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia Alisertib, Laboratory Biomarker Analysis, Pharmacological Study - Acute Megakaryoblastic Leukemia, Myelofibrosis | Not applicable | Unknown | Northwestern University | 26 | 2015-10-09 | 2021-05-26 |
| Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies Aldesleukin, Allogeneic CD56-positive CD3-negative Natural Killer Cells, Allogeneic Hematopoietic Stem Cell Transplantation - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 63 | 2013-06-11 | 2023-11-07 |
| Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia Azacitidine, Laboratory Biomarker Analysis, Pharmacological Study - Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 135 | 2006-11-22 | 2026-08-07 |
Leukemia, Megakaryoblastic, Acute (4) · Leukemia, Erythroblastic, Acute (3) · Leukemia, Myeloid, Acute (3) · Myelodysplastic Syndromes (3) · Anemia, Refractory (2) · Anemia, Refractory, with Excess of Blasts (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myelomonocytic, Chronic (2) · Blast Crisis (1) · HIV Infections (1) · Hematologic Neoplasms (1) · Leukemia, Myeloid, Accelerated Phase (1) · Lymphoma, Non-Hodgkin (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1)
Bone Marrow Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (4) · Leukemia, Myeloid (4) · Myeloproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Chronic Disease (3) · Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Anemia (2) · Myelodysplastic-Myeloproliferative Diseases (2) · Blood-Borne Infections (1)
fludarabine phosphate (2) · Azacitidine (1) · Busulfan (1) · Cord Blood Stem Cell Transplantation (1) · Cyclophosphamide (1) · MLN 8237 (1) · Peripheral Blood Stem Cell Transplantation (1) · Thiotepa (1) · Vorinostat (1) · Whole-Body Irradiation (1) · aldesleukin (1) · fludarabine (1)
Fred Hutchinson Cancer Center (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Northwestern University (1)
United States (4)
Brady Stein, MD (1) · Filippo Milano (1) · Lewis R Silverman (1) · Richard E Champlin (1)
N01CM17103 (1), N01CM62204 (1), P30CA013330 (1), P30CA060553 (1), R34HL142322 (1)